Cargando…
Interferon treatment for Japanese patients with favorable-risk metastatic renal cell carcinoma in the era of targeted therapy
PURPOSE: Single-agent interferon (IFN) is no longer regarded as a standard option for first-line systemic treatment of metastatic renal cell carcinoma (RCC) in Western countries. However, some patients with favorable-risk RCC may still achieve complete and long-lasting remission in response to IFN t...
Autores principales: | Sazuka, Tomokazu, Nihei, Naoki, Nakamura, Kazuyoshi, Sakamoto, Shinichi, Fukasawa, Satoshi, Komaru, Atsushi, Ueda, Takeshi, Igarashi, Tatsuo, Ichikawa, Tomohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355431/ https://www.ncbi.nlm.nih.gov/pubmed/25763124 http://dx.doi.org/10.4111/kju.2015.56.3.205 |
Ejemplares similares
-
Left ileal conduit: A case report
por: Nakamura, Kazuyoshi, et al.
Publicado: (2019) -
Development and External Validation of a Nomogram Predicting the Probability of Significant Gleason Sum Upgrading among Japanese Patients with Localized Prostate Cancer
por: Imamoto, Takashi, et al.
Publicado: (2011) -
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients
por: Kanesaka, Manato, et al.
Publicado: (2021) -
Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer
por: Baba, Haruki, et al.
Publicado: (2022) -
Successful treatment of metastatic bladder cancer by gemcitabine‐cisplatin re‐challenge after pembrolizumab
por: Arai, Takayuki, et al.
Publicado: (2021)